Fast-acting insulin aspart in people with type 2 diabetes: Earlier onset and greater initial exposure and glucose-lowering effect compared with insulin aspart.
Thomas R PieberEva SvehlikovaMartina BrunnerInge B HalbergKaren Margrete Due ThomsenHanne HaahrPublished in: Diabetes, obesity & metabolism (2019)
In people with T2D, faster aspart was associated with earlier onset and greater initial exposure and glucose-lowering effect compared with IAsp, as previously shown in people with type 1 diabetes.